Bachem to explore RNA at Bench and Bedside at California Conference

Bubendorf, Switzerland: –Peptide and Oligonucleotide manufacturers Bachem AG will attend the fourth ‘RNA at Bench and Bedside’ in-person conference at The Salk Institute in La Jolla, California.

The conference’s focus areas of RNA and DNA biology and preclinical therapeutics, clinical translation of nucleic acid gene therapies and nucleic acid delivery mechanisms accord with Bachem’s core capabilities in peptide and oligomer engineering.

Bachem will be represented at the event by Seema Zaidi from Bachem USA. Ms. Zaidi is Global Business Development for Oligonucleotide Therapeutics.

About Bachem

Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company, which has over 50 years of experience and expertise, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services.

Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange.

For further information, see www.bachem.com

About RNA at the Bench and Bedside

First hosted in 2016, the biennial RNA at the Bench and Bedside Conference brings together academics in basic and translational research and their peers in biotech companies and start-ups to foster dialogue and to spearhead collaborations. The conference focuses on the development of nucleic acid medicines including recent clinical successes, and current and upcoming challenges.

The fourth RNA at the Bench and Bedside Conference is a three-day event opening December 9 at The Salk Institute in La Jolla, California.

Day 1 of the conference will focus on RNA and DNA biology and preclinical therapeutics. The second day will discuss clinical translation of nucleic acid gene therapies and new technological developments from biotech companies, with the final day devoted to genome and epigenome editing and nucleic acid delivery mechanisms.

The event is organized by Ionis Pharmaceuticals, Alnylam Pharmaceuticals, The UCSD RNA Center, and Nature Biotechnology, with further details at: https://conferences.nature.com/event/RNAbenchtobedside4/summary

Resources

Click on RNA at the Bench and Bedside IV to see conference program.
Click on Bachem December 2024 Events for further information.
Click on Bachems News to see latest News & Events.